Lifeward Ltd.
LFWD- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001607962
No open-market purchases or sales by Lifeward Ltd. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $249.6K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Lifeward Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Lifeward Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Zamir Haggai | Director | 6,711 | Sep 10, 2026 | 1 |
| Greenwald Yonason | Director | 6,711 | Aug 28, 2026 | 1 |
| Gabay Avraham | Director | 13,643 | Aug 24, 2026 | 1 |
| Rose Keith Dale | Chief Medical Officer | 17,083 | May 20, 2026 | 1 |
| Rozenbaum Moshe H | Director | 11,485 | Apr 13, 2026 | 1 |
| Sigsbee William Mark | Director | 11,485 | Apr 13, 2026 | 1 |
| Kidron Nadav | Director | 7,657 | Mar 27, 2026 | 1 |
| Kidron Miriam | Director | 7,657 | Mar 27, 2026 | 1 |
| Adar Almog | Chief Financial Officer | 262,500Indirect | Mar 27, 2026 | 1 |
| Reznick Yehuda | Director | 7,657 | Mar 27, 2026 | 1 |
| Grant William Mark | President & CEO | – | Mar 27, 2026 | 1 |
| Lynch Jeannine | VP of Market Access & Strategy | 96,067 | Dec 12, 2025 | 1 |
| Poduska John William Sr | Director | 55,953Indirect | Aug 7, 2025 | 0 |
| Turk Joseph E Jr | Director | 86,457Indirect | Aug 7, 2025 | 0 |
| Marshall Robert J. Jr. | Director | 35,920 | Aug 7, 2025 | 0 |
| Richner Randel | Director | 57,487Indirect | Aug 7, 2025 | 0 |
| Levy Hadar | Director | 51,576Indirect | Aug 7, 2025 | 0 |
| Swinford Michael | Director | 45,960Indirect | Aug 7, 2025 | 0 |
| Jasinski Lawrence J | Chief Executive Officer | 98,728Indirect | May 22, 2025 | 0 |
| Lind Global Fund II LP | 10% Owner | 857,996Indirect | Jan 8, 2025 | 0 |
| Lawless Michael A | Chief Financial Officer | 4,150 | May 28, 2024 | 0 |
| Lind Global Macro Fund LP | 10% Owner | 0Indirect | Sep 28, 2023 | 0 |
| Dykan Jeff | Director | 119,157Indirect | Sep 19, 2023 | 0 |
| Dan Aryeh | Director | 71,062Indirect | Aug 17, 2023 | 0 |
| Remsberg Charles | Chief Sales Officer | 200,000Indirect | Aug 14, 2023 | 0 |
| Weisman Wayne | Director | 50,000Indirect | Aug 3, 2022 | 0 |
| Ichiki Yasushi | Director | 80,645Indirect | Aug 3, 2022 | 0 |
| Engelhardt Yohanan | Director | 80,585Indirect | Aug 3, 2022 | 0 |
| Gon Ori | Chief Financial Officer | 241,282Indirect | Jul 1, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2024 (view filing) | Aug 2 | 4 days | Lynch JeannineVP of Market Access & Strategy | SSaleOrdinary Shares, par value NIS 1.75 per share | −1.78K | $3.84 | −$6.85K | −3.5%49.3K after | 10b5-1 |
| Aug 6, 2024 (view filing) | Aug 2 | 4 days | Jasinski Lawrence JChief Executive Officer | SSaleOrdinary Shares, par value NIS 1.75 per share | −2.67K | $3.84 | −$10.2K | −2.5%103.3K after | |
| Sep 4, 2024 (view filing) | Sep 3 | 1 day | Lynch JeannineVP of Market Access & Strategy | SSaleOrdinary Shares, par value NIS 1.75 per share | −1.63K | $3.30 | −$5.36K | −3.3%47.7K after | 10b5-1 |
| Sep 16, 2024 (view filing) | Sep 13 | 3 days | Jasinski Lawrence JChief Executive Officer | SSaleOrdinary Shares, par value NIS 1.75 per share | −2.67K | $3.26 | −$8.71K | −2.6%100.6K after | |
| Nov 25, 2024 (view filing) | Nov 20 | 5 daysLate | Swinford MichaelDirector | PPurchaseOrdinary Shares, par value NIS 1.75 per share | +16.5K | $1.84 | +$30.3K | +164.1%26.5K after | |
| Nov 26, 2024 (view filing) | Nov 22 | 4 days | Swinford MichaelDirector | PPurchaseOrdinary Shares, par value NIS 1.75 per share | +16.9K | $1.83 | +$30.9K | +63.8%43.4K after | |
| Nov 27, 2024 (view filing) | Nov 25 | 2 days | Swinford MichaelDirector | PPurchaseOrdinary Shares, par value NIS 1.75 per share | +21.6K | $2.03 | +$43.9K | +49.8%65.0K after | |
| Dec 17, 2024 (view filing) | Dec 13 | 4 days | Turk Joseph E JrDirector | PPurchaseOrdinary Shares, par value NIS 1.75 per share | +6.00K | $1.69 | +$10.1K | +47.9%18.5K after | |
| Dec 17, 2024 (view filing) | Dec 13 | 4 days | Richner RandelDirector | SSaleOrdinary Shares, par value NIS 1.75 per share | −4.29K | $1.68 | −$7.20K | −100.0%0 after | |
| Jan 8, 2025 (view filing) | Jan 6-7 | 2 days | Lind Global Fund II LP10% Owner | SSaleOrdinary Shares, par value NIS 1.75 per share | −573.1K | $2.89 | −$1.66M | −40.0%858.0K after | 4 lots |
| May 22, 2025 (view filing) | May 21 | 1 day | Jasinski Lawrence JChief Executive Officer | SSaleOrdinary Shares, par value NIS 1.75 per share | −1.91K | $1.26 | −$2.41K | −1.9%98.7K after | |
| Sep 4, 2025 (view filing) | Sep 2 | 2 days | Lynch JeannineVP of Market Access & Strategy | SSaleOrdinary Shares, par value NIS 1.75 per share | −1.59K | $0.64 | −$1.02K | −3.3%46.1K after |